Preoperative albumin/globulin ratio has predictive value for patients with laryngeal squamous cell carcinoma

Wan-Zhi Chen; Shi-Tong Yu; Rong Xie; Yun-Xia Lv; De-Bin Xu; Ji-Chun Yu

doi:10.18632/oncotarget.18443

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Preoperative albumin/globulin ratio has predictive value for patients with laryngeal squamous cell carcinoma

Wan-Zhi Chen, Shi-Tong Yu, Rong Xie, Yun-Xia Lv, De-Bin Xu and Ji-Chun Yu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:48240-48247. https://doi.org/10.18632/oncotarget.18443

Metrics: PDF 1697 views | HTML 3340 views | ?

Abstract

Wan-Zhi Chen1,*, Shi-Tong Yu2,*, Rong Xie1, Yun-Xia Lv1, De-Bin Xu1 and Ji-Chun Yu1

1Department of Thyroid and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

2Department of Otolaryngology, Head and Neck Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

*These authors have contributed equally to this work

Correspondence to:

Ji-Chun Yu, email: [email protected]

Keywords: albumin/globulin ratio, laryngeal squamous cell carcinoma, prognostic marker

Received: February 20, 2017 Accepted: April 29, 2017 Published: June 12, 2017

ABSTRACT

This study evaluated the predictive value of the preoperative albumin/globulin ratio (AGR) in laryngeal squamous cell carcinoma (LSCC) retrospectively, which has not been reported before. The current study enrolled 241 newly diagnosed LSCC patients in the Second Affiliated Hospital of Nanchang University between January 2005 and December 2010. The optimal AGR cut-off value for overall survival (OS) was determined to be 1.28. Univariate survival analysis identified sex, low AGR, T classification, histological grade and nodal metastasis as factors associated with poor OS. Additionally, a low AGR, T classification, nodal metastasis, and histological grade were associated with poor disease-free survival (DFS) in LSCC patients. In multivariate survival analysis, nodal metastasis and a low AGR remained significant for OS and DFS. Our preliminary study revealed that low preoperative AGR could serve as a valuable and easily-assessed blood-based indicator to predict the prognosis of LSCC patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18443

Publication Alerts

Oncoscience

Post-Publication Promotion

Research Papers:

Preoperative albumin/globulin ratio has predictive value for patients with laryngeal squamous cell carcinoma

Abstract